Last $84.98 USD
Change Today -0.90 / -1.05%
Volume 140.7K
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

heartware international inc (HTWR) Snapshot

Open
$85.66
Previous Close
$85.88
Day High
$86.04
Day Low
$84.55
52 Week High
01/14/14 - $105.84
52 Week Low
10/7/13 - $69.31
Market Cap
1.4B
Average Volume 10 Days
285.3K
EPS TTM
$-3.42
Shares Outstanding
17.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HEARTWARE INTERNATIONAL INC (HTWR)

heartware international inc (HTWR) Related Businessweek News

No Related Businessweek News Found

heartware international inc (HTWR) Details

HeartWare International, Inc., a medical device company, is engaged in developing and manufacturing miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure in the United States and internationally. The company offers HeartWare Ventricular Assist System, which includes a VAD, or blood pump, patient accessories, and surgical tools designed to provide circulatory support for patients in the advanced stage of heart failure. It is also developing the MVAD, a miniaturized blood pump, intended for chronic heart failure patients; and the SYNERGY Circulatory Support System, a partial support system designed to treat less sick, ambulatory, chronic heart failure patients who are not yet inotrope-dependent. In addition, HeartWare International, Inc. collaborates with Dualis MedTech GmbH for the development of an implantable system. The company markets its products directly to cardiac centers and hospitals, as well as through medical device distributors. HeartWare International, Inc. is headquartered in Framingham, Massachusetts.

569 Employees
Last Reported Date: 03/3/14

heartware international inc (HTWR) Top Compensated Officers

Chief Executive Officer, President, Managing ...
Total Annual Compensation: $524.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $147.7K
Chief Scientific Officer and Executive Vice P...
Total Annual Compensation: $324.1K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $318.9K
Senior Vice President of Sales and Marketing
Total Annual Compensation: $288.6K
Compensation as of Fiscal Year 2012.

heartware international inc (HTWR) Key Developments

Heartware International Inc. Announces Unaudited Consolidated Financial Results for the Fourth Quarter and Full Year Ended December 31, 2013

Heartware International Inc. announced unaudited consolidated financial results for the fourth quarter and full year ended December 31, 2013. The company announced revenue of $53.1 million for the fourth quarter ended December 31, 2013, a 62% increase compared to $32.7 million in revenue for the same period of 2012. Net loss for the fourth quarter of 2013 was $22.0 million, or a $1.33 loss per basic and diluted share, compared to a $21.1 million net loss, or a loss of $1.46 per basic and diluted share, in the fourth quarter of 2012. The fourth quarter results included CircuLite's operations for the month of December, as well as approximately $6.7 million of non-recurring costs. Non-GAAP net loss per share for the fourth quarter of 2013 was $0.92 per basic and diluted share, compared to a loss of $1.46 per basic and diluted share in the fourth quarter of 2012. Loss from operations was $19,496,000 against $19,358,000 for the same period of last year. Loss before income taxes was $21,422,000 against $21,105,000 for the same period of last year. Non-GAAP net loss was $15,303,000 against $21,084,000 for the same period of last year. Non-GAAP net loss per basic and diluted share was $0.92 against $1.46 for the same period of last year. For the fiscal year 2013, the company generated revenue of $207.9 million, an 87% increase compared to revenue of $110.9 million in fiscal year 2012. Currency fluctuations benefitted revenue growth by approximately two percentage points in the fourth quarter, as well as on a full-year basis, in 2013 compared to the same periods in 2012. For the fiscal year ended December 31, 2013, the company recorded a net loss of $59.3 million, or a $3.69 loss per basic and diluted share, compared to an $87.7 million net loss, or a loss of $6.15 per basic and diluted share, in fiscal year 2012. Non-GAAP net loss per share for 2013 was $3.24 compared to a loss of $6.07 per basic and diluted share in 2012. Loss from operations was $47,546,000 against $77,594,000 for the same period of last year. Loss before income taxes was $58,844,000 against $87,718,000 for the same period of last year. Non-GAAP net loss was $52,004,000 against $86,583,000 for the same period of last year. Non-GAAP net loss per basic and diluted share was $3.24 against $6.07 for the same period of last year.

Heartware International Inc., Q4 2013 Earnings Call, Feb 27, 2014

Heartware International Inc., Q4 2013 Earnings Call, Feb 27, 2014

Heartware International Inc. to Report Q4, 2013 Results on Feb 27, 2014

Heartware International Inc. announced that they will report Q4, 2013 results at 11:00 PM, GMT Standard Time on Feb 27, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HTWR:US $84.98 USD -0.90

HTWR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ABIOMED Inc $24.64 USD +0.16
Sunshine Heart Inc $5.60 USD -0.10
Thoratec Corp $33.60 USD -0.32
View Industry Companies
 

Industry Analysis

HTWR

Industry Average

Valuation HTWR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.8x
Price/Book 7.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEARTWARE INTERNATIONAL INC, please visit www.heartware.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.